Search research articles
Contact Us
Filters
Showing results (791-800 of 865) with videos related to
Page
of 87
Sort By:
Plos Neglected Tropical Diseases
|
March 17, 2010
A randomized controlled trial of local heat therapy versus intravenous sodium stibogluconate for the treatment of cutaneous Leishmania major infection
Naomi E Aronson, Glenn W Wortmann, William R Byrne, et al.
Blood
|
June 26, 2009
Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells
Francois Romagné, Pascale André, Pieter Spee, et al.
Optics Express
|
October 17, 2014
Mid-infrared supercontinuum generation to 12.5μm in large NA chalcogenide step-index fibres pumped at 4.5μm
Irnis Kubat, Christian S Agger, Uffe Møller, et al.
Cancer Immunology, Immunotherapy : CII
|
October 29, 2013
Elotuzumab directly enhances NK cell cytotoxicity against myeloma via CS1 ligation: evidence for augmented NK cell function complementing ADCC
Shauna M Collins, Courtney E Bakan, Gina D Swartzel, et al.
European Journal of Orthopaedic Surgery & Traumatology : Orthopedie Traumatologie
|
July 24, 2025
Identifying risk factors for systemic complications following fracture-related infection
Robin M Litten, Doriann M Alcaide, Robert W Rutz, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 8, 2010
Discovery of novel and orally active FXR agonists for the potential treatment of dyslipidemia & diabetes
Hans G F Richter, Gregory M Benson, Denise Blum, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 14, 2009
Improved nonrelapse mortality and infection rate with lower dose of antithymocyte globulin in patients undergoing reduced-intensity conditioning allogeneic transplantation for hematologic malignancies
Mehdi Hamadani, William Blum, Gary Phillips, et al.
Blood
|
March 12, 2014
A phase 1 study of the PI3Kδ inhibitor idelalisib in patients with relapsed/refractory mantle cell lymphoma (MCL)
Brad S Kahl, Stephen E Spurgeon, Richard R Furman, et al.
Leukemia & Lymphoma
|
July 4, 2015
Tocilizumab for steroid refractory acute graft-versus-host disease
Julianna V F Roddy, Bradley M Haverkos, Ali McBride, et al.
Cancers
|
November 26, 2022
Longitudinal Survival Outcomes in Allogeneic Stem Cell Transplantation: An Institutional Experience
Justin Jiang, Audrey M Sigmund, Qiuhong Zhao, et al.
Page
of 87
Search research articles
Search
Showing results (791-800 of 865) with videos related to
Sort By:
Page
of 87
Plos Neglected Tropical Diseases
|
March 17, 2010
A randomized controlled trial of local heat therapy versus intravenous sodium stibogluconate for the treatment of cutaneous Leishmania major infection
Naomi E Aronson, Glenn W Wortmann, William R Byrne, et al.
Blood
|
June 26, 2009
Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells
Francois Romagné, Pascale André, Pieter Spee, et al.
Optics Express
|
October 17, 2014
Mid-infrared supercontinuum generation to 12.5μm in large NA chalcogenide step-index fibres pumped at 4.5μm
Irnis Kubat, Christian S Agger, Uffe Møller, et al.
Cancer Immunology, Immunotherapy : CII
|
October 29, 2013
Elotuzumab directly enhances NK cell cytotoxicity against myeloma via CS1 ligation: evidence for augmented NK cell function complementing ADCC
Shauna M Collins, Courtney E Bakan, Gina D Swartzel, et al.
European Journal of Orthopaedic Surgery & Traumatology : Orthopedie Traumatologie
|
July 24, 2025
Identifying risk factors for systemic complications following fracture-related infection
Robin M Litten, Doriann M Alcaide, Robert W Rutz, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 8, 2010
Discovery of novel and orally active FXR agonists for the potential treatment of dyslipidemia & diabetes
Hans G F Richter, Gregory M Benson, Denise Blum, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 14, 2009
Improved nonrelapse mortality and infection rate with lower dose of antithymocyte globulin in patients undergoing reduced-intensity conditioning allogeneic transplantation for hematologic malignancies
Mehdi Hamadani, William Blum, Gary Phillips, et al.
Blood
|
March 12, 2014
A phase 1 study of the PI3Kδ inhibitor idelalisib in patients with relapsed/refractory mantle cell lymphoma (MCL)
Brad S Kahl, Stephen E Spurgeon, Richard R Furman, et al.
Leukemia & Lymphoma
|
July 4, 2015
Tocilizumab for steroid refractory acute graft-versus-host disease
Julianna V F Roddy, Bradley M Haverkos, Ali McBride, et al.
Cancers
|
November 26, 2022
Longitudinal Survival Outcomes in Allogeneic Stem Cell Transplantation: An Institutional Experience
Justin Jiang, Audrey M Sigmund, Qiuhong Zhao, et al.
Page
of 87